| 注册
首页|期刊导航|中国药业|我国红豆杉药材人工培植研究及思考

我国红豆杉药材人工培植研究及思考

贺宗毅 张德利 李卿 邢康康 陈仕江

中国药业2017,Vol.26Issue(17):1-5,5.
中国药业2017,Vol.26Issue(17):1-5,5.DOI:10.3969/j.issn.1006-4931.2017.17.001

我国红豆杉药材人工培植研究及思考

Research and Reflection on Artificial Cultivation of Taxus Spp. in China

贺宗毅 1张德利 2李卿 3邢康康 1陈仕江2

作者信息

  • 1. 重庆市中药研究院,重庆 400065
  • 2. 重庆市中药资源学重点实验室,重庆 400065
  • 3. 中国中医科学院·中药资源中心重庆分中心,重庆 400065
  • 折叠

摘要

Abstract

Objective To understand the artificial cultivation of Taxus Spp. medicinal resources and production capacity status of taxinol in China. Methods Through the literature search, the information provided by the industry and the way of network retrieval, the infor-mations of the cultivation base of Taxus Spp. were obtained, and the field investigation was conducted according to the collected infor-mations. Results Field investigations were conducted on 57 artificial cultivation bases of Taxus Spp. and factories in 13 provinces and cities, including Sichuan, Chongqing, Yunnan, Guizhou, Fujian, Zhejiang provinces and etc. The artificial cultivation bases were distributed in the eastern, southeast and southwest of China. The main varieties were Taxus media and Taxus chinensis, the main raising seedling models were seedling cultivation and cottage, the main business model was seedlings sold. Conclusion The enterprises mainly extract the precursor of taxinol for export, no manufacturers for producing total synthesis of taxinol were found. Therefore, taxinol and its preparations in the market will still depend on the extraction of Taxus Spp. .

关键词

红豆杉/紫杉醇/人工培植/思考

Key words

Taxus Spp./taxinol/artificial cultivation/reflection

分类

医药卫生

引用本文复制引用

贺宗毅,张德利,李卿,邢康康,陈仕江..我国红豆杉药材人工培植研究及思考[J].中国药业,2017,26(17):1-5,5.

基金项目

重庆市基本科研业务费计划项目[ 2015cstc-jbky-01906 ] ()

重庆市卫生局中医药科研项目[ zy201602093 ]. ()

中国药业

OACSTPCD

1006-4931

访问量3
|
下载量0
段落导航相关论文